|
|
my account
log out
|
Treatment Receptor Metastatic Drug Fulvestrant |
| Create: 08/22/2016 |
| Expired Date: | 03/15/2017 |
| Category: | Intermediates [Chemical] |
| Message: | Treatment Receptor Metastatic Drug Fulvestrant / Faslodex 129453-61-8 Anti Cancer Steroids Raw Powder Basic Info. CAS:129453-61-8 Purity:99% Appearance:white powder Synonyms: FASLODEX Chemical Name:(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol Molecular Fomular:C32H47F5O3S Molecular Weight:606.77 Density:1.201 g/cm3 Melting Point:104-106°C Boiling Point:674.8 °C at 760 mmHg Package:10g/foil bag Usage:To treat estrogen receptor positive metastatic breast cancer in postmenopausal women, with disease progression following antiestrogen therapy. |
![]() | |
| City: | Guangzhou Guangdong[CN]
|
| Location: |
|
| Aug 25 2016 | Glutathione | 559 | |
| Aug 25 2016 | Aging Coenzyme Q10 | 544 | |
| Aug 25 2016 | Creatine | 500 | |
| Aug 25 2016 | Whitening Arbutin | 534 | |
| Aug 25 2016 | Branch Chain Amino Acid Bcaa | 574 | |
| Aug 25 2016 | Material Chitosan | 488 | |
| Aug 25 2016 | Ropivacaine Hcl | 508 | |
| Aug 25 2016 | Prilocaine HCl | 519 | |
| Aug 25 2016 | Proparacaine HCl | 536 | |
| Aug 25 2016 | Levobupivacaine HCl | 562 |
| Copyright © toextrade Inc. All rights reserved. Contact us |